Total planned funding: $1,678,489,723
Clear active filters
Nigeria
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Nigeria | $1,678,489,723 |
Organizational Types
Unknown | $391,152,068 |
Private Contractor | $370,635,760 |
NGO | $363,900,204 |
University | $163,046,779 |
Implementing Agency | $157,496,369 |
Own Agency | $150,751,807 |
FBO | $69,095,471 |
Host Country Government Agency | $5,289,982 |
Other USG Agency | $4,433,283 |
Multi-lateral Agency | $2,688,000 |
Program Areas
Treatment | $645,429,411 |
Care | $323,499,271 |
Governance and Systems | $280,164,421 |
Prevention | $257,828,491 |
Management and Operations | $116,473,409 |
Testing | $55,094,720 |
Budget Codes
HTXS: Treatment: Adult Treatment | $312,924,922 |
HTXD: Treatment: ARV Drugs | $308,968,934 |
HKID: Care: Orphans and Vulnerable Children | $137,254,909 |
HBHC: Care: Adult Care and Support | $131,930,842 |
HLAB: Laboratory Infrastructure | $130,237,265 |
HVMS: Management and Operations | $116,473,409 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $104,573,573 |
OHSS: Health Systems Strengthening | $93,230,375 |
HVOP: Sexual Prevention: Other Sexual Prevention | $68,208,863 |
HVSI: Strategic Information | $56,696,781 |
HVCT: Testing: HIV Testing and Counseling | $55,094,720 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $41,931,257 |
HVTB: Care: TB/HIV | $40,706,604 |
HMBL: Biomedical Prevention: Blood Safety | $25,333,644 |
PDTX: Treatment: Pediatric Treatment | $23,535,555 |
HMIN: Biomedical Prevention: Injection Safety | $17,781,154 |
PDCS: Care: Pediatric Care and Support | $13,606,916 |
Top Partner Programs
Not Available:
$329,647,001
Countries/Regions
FHI 360:
$170,280,068
Countries/Regions
USG Aggregated Agencies:
$90,843,086
Countries/Regions
Harvard University:
$87,819,808
Countries/Regions